Uveitis occurrence in early inflammatory back pain. Five years data from the prospective French nationwide DESIR cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/33166730/

Can SARS-CoV-2 trigger reactive arthritis? (2020)
https://pubmed.ncbi.nlm.nih.gov/33127461/

ASAS Health Index: The “All in One” for Spondyloarthritis Evaluation? (2020)
https://pubmed.ncbi.nlm.nih.gov/33004479/

Deciding who to treat with biologic disease-modifying antirheumatic drugs in axial spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/32635788/

From observational studies to personalized treatment in spondylarthritis: focus on IL-17 inhibition. (2020)
https://pubmed.ncbi.nlm.nih.gov/32529902/

Toward a tailored therapeutic prescription for patients with axial spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/32534199/

Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases. (2020)
https://pubmed.ncbi.nlm.nih.gov/32999885/

Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial. (2020)
https://pubmed.ncbi.nlm.nih.gov/32521324/

Share Reactive Arthritis: Treatment Challenges and Future Perspectives. (2020)
https://pubmed.ncbi.nlm.nih.gov/32458153/

Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches. (2020)
https://pubmed.ncbi.nlm.nih.gov/32428691/

Prognostic factors of good response to DMARDs in psoriatic arthritis: a narrative review. (2020)
https://pubmed.ncbi.nlm.nih.gov/32306777/

Are the recommendations for the use of anti-TNF drugs during axial spondyloarthritis relevant for non-radiographic forms? (2020)
https://pubmed.ncbi.nlm.nih.gov/32147568/

Ultrasonographic Involvement of the anterior chest wall in Spondyloarthritis: Factors associated with 5-years structural progression. A prospective study in 58 patients. (2020)
https://pubmed.ncbi.nlm.nih.gov/32147567/

5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohort. (2020)
https://pubmed.ncbi.nlm.nih.gov/32396521/

Dactylitis in early spondyloarthritis. Data from the prospective French national cohort DESIR. (2020)
https://pubmed.ncbi.nlm.nih.gov/31958574/

Cardiovascular risk in psoriatic arthritis, a narrative review. (2020)
https://pubmed.ncbi.nlm.nih.gov/31958573/

Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism? (2020)
https://pubmed.ncbi.nlm.nih.gov/31324528/

Local sacroiliac injections in the treatment of spondyloarthritis. What is the evidence? (2020)
https://pubmed.ncbi.nlm.nih.gov/31216488/

Effect of Gut Involvement in Patients with High Probability of Early Spondyloarthritis: Data from the DESIR Cohort. (2020)
https://pubmed.ncbi.nlm.nih.gov/31154418/

New targeted therapies in spondyloarthritis: what are the limits? (2019)
https://pubmed.ncbi.nlm.nih.gov/30943857/

Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort. (2019)
https://pubmed.ncbi.nlm.nih.gov/30620273/

Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis. (2019)
https://pubmed.ncbi.nlm.nih.gov/30500270/

Efficacy of new treatments for dactylitis of psoriatic arthritis: update of literature review. (2019)
https://pubmed.ncbi.nlm.nih.gov/30328022/

Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus. (2019)
https://pubmed.ncbi.nlm.nih.gov/30243782/

Aerobic exercise for axial spondyloarthritis – its effects on disease activity and function as compared to standard physiotherapy: A systematic review and meta-analysis. (2019)
https://pubmed.ncbi.nlm.nih.gov/30187695/

Vascular involvement in axial spondyloarthropathies. (2019)
https://pubmed.ncbi.nlm.nih.gov/29787813/

Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis. (2018)
https://pubmed.ncbi.nlm.nih.gov/29769586/

2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis. (2018)
https://pubmed.ncbi.nlm.nih.gov/29407043/

Disease activity in ankylosing spondylitis: the global therapeutic target. (2018)
https://pubmed.ncbi.nlm.nih.gov/29247127/

Spondyloarthritis: An expanding cast of cellular actors. (2018)
https://pubmed.ncbi.nlm.nih.gov/28495522/

Spondyloarthritis: Harlequin or Chameleon? (2017)
https://pubmed.ncbi.nlm.nih.gov/28864662/

Deaths Associated with Ankylosing Spondylitis in France from 1969 to 2009. (2017)
https://pubmed.ncbi.nlm.nih.gov/28298562/